SMARCA1 and Ewing sarcoma: However, consistent with this idea, Ewing sarcoma is exquisitely sensitive to this drug and known to dysregulate SWI/SNF by altering the distribution of SWI/SNF through a different mechanism (Boulay et al, 2017).